The Healing Power of Fat

digital rendering of inside throat


Fat cells are increasingly being used in cosmetic and reconstructive plastic surgery, and now UConn Health has restored one patient’s lost voice by leveraging the power of fat.

In 2013, Ed Favolise, 70, a retired superintendent of schools in Connecticut, had surgery to remove a precancerous tumor from his chest. Part of the tumor encased a nerve that was severed during surgery, leaving his right vocal cord paralyzed and a major gap between his vocal cords.

For three years, Favolise’s voice was limited to a squeaky, high-pitched whisper while he pursued remedies at three different medical centers. After five surgeries and continuous vocal therapy, Favolise turned to the Voice Center at UConn Health.
Dr. Denis Lafreniere, chief of the Division of Otolaryngology, teamed up with Dr. Andrew Chen, chief of the Division of Plastic Surgery, to offer an innovative solution.

In the operating room, Lafreniere and Chen withdrew fat cells from Favolise’s abdomen, processed and measured them to make sure they had enough pure fat cells, and placed them directly into his injured vocal cord via a needle injector through a laryngoscope. The result? A permanently plumped vocal cord that’s in the proper position to contact the left vocal cord.

“My speech improved immediately and significantly,” says Favolise. “My experience shows that sometimes you need to be willing to take a chance on a pretty surprising, promising alternative medical solution and procedure.”


Related Articles

  • Lab Notes – Summer 2017

    Discover the connection between chili peppers and marijuana, the signature to look for in dangerous melanomas, the physiology behind Angelman syndrome, and why our corneas resist tumor formation in this round-up of recently published UConn Health research.

  • Working Together for Better Public Health

    Q&A with Dr. Raul Pino, commissioner of the Connecticut Department of Public Health and a UConn Health board member.

  • Matching Medicine to the MS Patient

    Why do drugs tested for primary progressive multiple sclerosis work in the lab but fail in real patients? Each patient has uniquely defective stem cells.

  • Honor Roll – Summer 2017

    Radenka Maric, Ph.D., was named UConn’s vice president for research effective July 1, 2017. Maric was previously the CT Clean Energy Fund Professor of Sustainable Energy in the UConn School of Engineering. Dr. Anthony G. Alessi received the 2017 President’s Award at the American Academy of Neurology’s 69th annual meeting, held this April in Boston. […]